ArticleMolecular neurobiology2025
miR-133b-3p Mitigates D-Galactose-Induced Hippocampal Neuron Aging Through Autophagy Regulation via the MAPK/ERK Signaling Pathway.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tu-Si-Zi-Wan reduces D-galactose-induced hepatic and cerebral oxidative damage in aging mice via the Nrf2/ARE pathway.Metabolic brain disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Although remarkable progress has been achieved in contemporary medical research, effective drugs or prophylactic approaches targeting neurodegenerative diseases associated with aging are still limited. Increasing evidence suggests that microRNAs (miRNAs) are closely associated with age-related neurological diseases, positioning them as novel therapeutic targets. Autophagy in neurons participates in the renewal of damaged or aged endoplasmic reticulum, mitochondria, other organelles, and aggregated proteins during aging. This study evaluated the anti-aging mechanism of miR-133b-3p in D-galactose (D-gal)-induced hippocampal neurons. A mouse aging model was established by long-term D-gal injection and compared with 18-month-old naturally aged mice to verify and confirm the successful establishment of the aging model, providing a more reliable experimental basis for exploring the changes in mechanisms during aging.Compared with young mice, the D-gal group and the 18 M group showed decreased learning and memory abilities, altered neuronal structures, downregulated miR-133b-3p expression, and inhibited MAPK/ERK signaling pathway and autophagy. In addition, in the D-gal-induced HT22 cell senescence model, autophagy was inhibited, and the expression of the age-related protein p53 was downregulated. We also found that miR-133b-3p overexpression under aging conditions can activate autophagy via the MAPK/ERK signaling pathway and exert neuroprotection in hippocampal neurons. However, the effect of miR-133b-3p in reducing cellular aging damage was weakened when the MAPK/ERK signaling pathway was blocked or autophagy was inhibited.This study revealed the significant mechanism whereby miR-133b-3p protects hippocampal neurons in aging mice. miR-133b-3p alleviates D-gal-induced cellular aging damage by activating autophagy through the MAPK/ERK signaling pathway.
Indexed as
Identifiers
41217665What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.